Dose-dependent ultrastructural changes in rat cornea after oral methylphenidate administration

Saudi Medical Journal

Volumn 29, Issue 4, 2008, Pages 498-502

  Gozil, Rabet ^a   Take, Gulnur ^a   Bahcelioglu, Meltem ^a   Tunc, Erdinc ^b   Oktem, Hale ^a   Caglar, Guleser ^a   Calguner, Engin ^a   Erdogan, Deniz ^a  

^a GAZI UNIVERSITY   (Turkey)

^b UFUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBER; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEGENERATION; CELL ULTRASTRUCTURE; CELL VACUOLE; CHROMATIN CONDENSATION; CONTROLLED STUDY; CORNEA CELL; CORNEA DYSTROPHY; CORNEA EPITHELIUM; DOSE RESPONSE; DRUG DOSE COMPARISON; ELECTRON MICROSCOPY; FEMALE; NONHUMAN; RAT; TOXICITY TESTING; WISTAR RAT; ANIMAL; CORNEA; DRUG EFFECT; ULTRASTRUCTURE;

ANIMALS; CORNEA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; METHYLPHENIDATE; RATS; RATS, WISTAR;

EID: 46749155173     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998; 351: 429-433.
2. Kollins SH, MacDonald EK, Rush CR. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: A review. Pharmacol Biochem Behav 2001; 68: 611-627.
3. Swanson JM, Volkow ND. Serum and brain concentrations of methylphenidate: Implications for use and abuse. Neurosci Biobehav Rev 2003; 27: 615-621.
4. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psych 2002; 41(Suppl 2): S26-S49.
5. Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND. Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharmacol Biochem Behav 2007; 87: 426-433.
6. Schweri MM, Skolnick P, Rafferty MF, Rice KC, Janowsky AJ, Paul SM. [3H]Threo-(+/)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: Correlation with the stimulant properties of ritalinic acid esters. J Neurochem 1985; 45: 1062-1070.
7. Gatley SJ, Pan D, Chen R, Chaturvedi G, Ding YS. Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci 1996; 58: 231-239.
8. Gerasimov MR, Franceschi M, Volkow ND, Gifford A, Gatley SJ, Marsteller D, et al. Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study. J Pharmacol Exp Ther 2000; 295: 51-57.
9. Grueb M, Wallenfels-Thilo B, Denk O, Mielke J, Reinthal E, Rohrbach JM, et al. Monoamine receptors in human corneal epithelium and endothelium. Acta Ophthalmol Scand 2006; 84: 110-115.
10. Cavallotti C, Pescosolido N, Artico M, Feher J. Localization of dopamine receptors in the rabbit cornea. Cornea 1999; 18: 721-728.
11. Reis RAM, Ventura ALM, Kubrusly RCC, de Mello MCF, de Mello FG. Dopaminergic signaling in the developing retina. Brain Res Rev 2007; 54: 181-188.
12. El-Zein RA, Abdel-Rahman SZ, Hay MJ, Lopez MS, Bondy ML, Morris DL, et al. Cytogenetic effects in children treated with methylphenidate. Cancer Lett 2005; 230: 284-291.
13. Benes FM. Brain development, VII. Human brain growth spans decades. A J Psychiatry 1998; 155: 1489.
14. Castner SA, Goldman-Rakic PS. Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology 1999; 20: 10-28.
15. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, et al. Brain development during childhood and adolescence: A longitudinal MRI study. Nat Neurosci 1999; 2: 861-863.
16. LeBlanc-Duchin D, Taukulis HK. Behavioral reactivity to a noradrenergic challenge after chronic oral methylphenidate (ritalin) in rats. Pharmacol Biochem Behav 2004; 79: 641-649.
17. Pilon AF, Scheiffle J. Ulcerative keratitis associated with crack-cocaine abuse. Cont Lens Anterior Eye 2006; 29: 263-267.
18. Lu CK, Kuang TM, Chou JC. Methylphenidate (Ritalin)-associated cataract and glaucoma. J Chin Med Assoc 2006; 69: 589-590.
19. Cavallotti C, Pescosolido N, Pescosolido V, Iannetti G. Determination of D1 receptors in the human uveo scleral tissue by light microscope autoradiography. Int Ophthalmol 2001; 23: 171-179.
20. Crosson CE, Beuerman RW, Klyce SD. Dopamine modulation of active ion transport in rabbit corneal epithelium. Invest Ophthalmol Vis Sci 1984; 25: 1240-1245.